TAK

Takeda Pharmaceutical Company Limited
D

TAK

15.000
USD
0.20
(1.32%)
قبل الجلسة
حجم التداول
10
الربح لكل سهم
137
العائد الربحي
4.43
P/E
52
حجم السوق
47,373,297,090
أصول ذات صلة
AZN
AZN
0.700
(0.89%)
79.180 USD
BMY
BMY
0.645
(1.35%)
48.465 USD
GILD
GILD
-0.680
(-0.57%)
118.320 USD
GSK
GSK
0.105
(0.27%)
39.325 USD
JNJ
JNJ
1.930
(1.10%)
176.650 USD
LLY
LLY
16.80
(2.45%)
701.25 USD
MRK
MRK
1.500
(1.81%)
84.250 USD
NVO
NVO
1.500
(2.95%)
52.420 USD
NVS
NVS
2.080
(1.70%)
124.210 USD
PFE
PFE
0.055
(0.22%)
25.155 USD
SNY
SNY
0.745
(1.52%)
49.770 USD
المزيد
الأخبار المقالات

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.